Health Care

2693 posts

Marvel Biosciences advancing autism drug for children

Marvel Biosciences announces two pediatric-friendly versions of its drug candidate, MB-204, which may help to treat autism and depression.

Voice is becoming the new frontier in safety AI

MindBio Therapeutics (CSE:MBIO) is a biotechnology and applied AI company commercializing proprietary voice analytics technology.

Buzz on the Bullboards: Return trajectories vs emerging threats

Global markets entered this week uneasy, as geopolitics once again took centre stage. Traders brace for volatility tied to Middle East.

MindBio completes development of platform for voice‑based intoxication detection

MindBio (CSE:MBIO) launched Intox Collect, expanding and accelerating voice based data collection for detecting drug and alcohol impairment.
NurExone Biologic Inc

NurExone Biologic: Beneficiary of US legislative change on stem cell therapy?

© 2026 Dr. Reuter Investor Relations. Article written by Sabine Lembert. All rights reserved. Stem cells are among the great...

Soleno Therapeutics shares jump nearly 40% on $2.9 billion takeout deal

Soleno Therapeutics (NASDAQ:SLNO) shares rallied after Neurocrine Biosciences agreed to acquire the company for US$2.9 billion.

Cannabix Technologies scores first marijuana breath test sales to construction sector

Cannabix Technologies (CSE:BLO) completed its first commercial sale of its Marijuana Breath Test system to a major construction company.

Dream Water Kids Sleep Gummies set for US summer debut

Delivra Health (TSXV:DHB) will launch a new line of kids sleep gummies under its Dream Water brand across the US market this June.

Buzz on the Bullboards: Oil shock, biotech breakthroughs and new tech

Global equities lurched from rally to rout since the U.S.–Israel strikes on Iran ignited a regional war and shutdown of the Strait of Hormuz.

Quit smoking with psychedelics? A new frontier for treatment — and investors

A new Johns Hopkins study found that a single dose of psilocybin, combined with therapy, helped smokers stay cigarette free at six months.

New bladder cancer drug may sharpen radiation’s aim

Theralase Technologies proves that its Rutherrin drug holds the potential to enhance radiation against non-muscle invasive bladder cancer.

FDA grants full approval to Pfizer’s colorectal cancer treatment

The FDA granted full approval to Pfizer’s (NYSE:PFE) BRAFTOVI + cetuximab + fluorouracil based chemotherapy for adults.

Buzz on the Bullboards: Market momentum returns to the TSX?

With markets buzzing on commodity rebounds and fresh economic signals, the TSX is alive with momentum—and...
Organigram

Organigram reports revenue boost in Q1

Organigram (TSX:OGI) reported its Q1 2026 revenue and profit surged, with net revenue up 49 per cent to $63.5M.

Buzz on the Bullboards: Geopolitics are back in the driver’s seat

Geopolitical risk is re‑pricing assets again A renewed wave of geopolitical flashpoints has been rippling through...

MindBio debuts AI speech tool to spot substance abuse

MindBio Therapeutics (CSE:MBIO) develops the world's first AI prediction tool for drug and alcohol intoxication using voice analysis.
The Market Online Video

Developing a neurosciences platform with potential applications across several indications

In this Capital Compass episode, Marvel Biosciences outlines progress on MB-204, its neuroscience platform targeting autism, Rett syndrome, Fragile X, and Alzheimer’s disease ahead…